Solid Biosciences Inc.
Develops gene therapies for rare neuromuscular and cardiac diseases.
SLDB | US
Overview
Corporate Details
- ISIN(s):
- US83422E2046
- LEI:
- Country:
- United States of America
- Address:
- 500 RUTHERFORD AVENUE, 2129 CHARLESTOWN
- Website:
- https://www.solidbio.com/
Description
Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates. The company develops treatments for rare and devastating neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia (CPVT), and various forms of dilated cardiomyopathy. In addition to its therapeutic pipeline, Solid Biosciences develops enabling technologies, such as innovative libraries of genetic regulators, to improve gene therapy delivery. The company's mission is to improve the lives of patients by uniting experts in science, technology, and disease management.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Solid Biosciences Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Solid Biosciences Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Solid Biosciences Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
